BiotechTube
Home/CoA Therapeutics/Agnieszka 'AJ' Jurecka, M.D., Ph.D.
A'

Agnieszka 'AJ' Jurecka, M.D., Ph.D.

Vice President, Clinical Development

CoA Therapeutics

Therapeutic Areas

Rare Genetic DiseasesMetabolic DisordersNeurodegeneration

CoA Therapeutics Pipeline

DrugIndicationPhase
BBP-671Pantothenate Kinase-Associated Neurodegeneration (PKAN)Phase 1

Leadership Team at CoA Therapeutics

CS
Christine Siu
Chief Executive Officer, in Residence
US
Uma Sinha, Ph.D.
Chief Scientific Officer
AW
Anna Wade, Ph.D.
Chief Operating Officer
JP
Jennifer Pavillard
Vice President, Regulatory Affairs
NK
Neil Kumar, Ph.D.
Board of Directors
View full CoA Therapeutics profile